site map  

QUESTIONS?

+1 (802) 878-1777

hti@haemtech.com

ORDERING

Human Proteins

Bovine Proteins

Mouse Proteins

Other Species

Inhibitors

Substrates

Antibodies

Sample Collection Tubes

Deficient Plasmas

Assay Kits

Pricing

HOME PAGE

QUESTIONS?

+1 (802) 878-1777

hti@haemtech.com

Coagulation Factor V

ACTIVATION OF FACTOR V BY ALPHA-THROMBIN.  The activation of single chain factor V (330,000) by alpha-thrombin is represented.  Arrows indicate the site at which factor V is cleaved by thrombin to yield two activation peptides (71,000 and 120,000), in addition to the heavy (94,000) and light (74,000) chains which form Va.  The heavy and light chains of factor Va remain non-covalently associated in the presence of calcium ions.

PURCHASING AND PRODUCT INFORMATION

Catalog Number HCV-0100 BCV-1100	Description Human Factor V Bovine Factor V	Size 50 µg 100 µg	Formulation 50% (vol/vol) glycerol/H2O 50% (vol/vol) glycerol/H2O
Storage -20oC	Purity >95% by SDS-PAGE	Activity Determination Clotting assay	Shelf Life (properly stored) 6 months
	Sample Gel Information: Gel: Novex 4-12% Bis-Tris Load: Human Factor V, 1 µg per lane Buffer: MOPS Standard: SeeBluePlus 2; Myosin (191 kDa), Phosphorylase B (97 kDa), BSA (64 kDa), Glutamic Dehydrogenase (51 kDa), Alcohol Dehydrogenase (39 kDa), Carbonic Anhydrase (28 kDa), Myoglobin Red (19 kDa), Lysozyme (14 kDa) *Factor V is a very labile protein. Some degraded fragments are usually noticeable in preparations.
Sample publications referencing our Factor V: Ofosu, F., et al., Biochem. J. (1992) 283, 893–897. (Factor V Activation) Ainle, F., et al., Blood. 2009 114: 1658-1665 (Inhibition of Factor V activation) Weeterings, C., et al., Blood 2008 112: 3227-3233 (Thrombin generation) Yang, X., et al, Biochem. J. (1990) 272, 399-406 (Activation of Factor V) This publication list is not all encompassing, and is only meant to provide limited examples of how Haematologic Technologies' products are used.  We encourage you to search the literature for other examples pertinent to your experimentation, and to contact us with any technical questions.
U.S. Pricing	Product inquiry	SAMPLE DATA SHEET	ORDER NOW!

Overview of Factor V

Factor V is a large, single chain, plasma glycoprotein which is an essential component in the blood coagulation cascade (1). During coagulation, the procofactor, factor V, is converted to the active cofactor, factor Va, via limited proteolysis by the serine protease alpha-thrombin (illustrated above), and less efficiently by factor Xa. The active cofactor is composed of an NH₂-terminal derived heavy chain (Mr=94,000) and a COOH-terminal derived light chain (Mr=74,000) which remain non-covalently associated in the presence of calcium ions. Factor Va serves as a cofactor for the serine protease factor Xa. Factor Va and Xa assemble on a phospholipid surface in a non-covalent and calcium ion-dependent manner, to form the prothrombinase complex. The prothrombinase complex is responsible for the rapid conversion of the zymogen prothrombin to the active serine protease, alpha-thrombin. Assembly of the prothrombinase complex increases the rate at which prothrombin is converted to thrombin by nearly 300,000-fold relative to the rate with factor Xa alone. Down regulation of the prothrombinase complex is accomplished partly through the inactivation of factor Va by activated protein C.

Human factor V is prepared from fresh frozen human plasma using immunoaffinity chromatography as described by Katzmann and coworkers (2). Bovine factor V is prepared from fresh bovine plasma using conventional chromatographic techniques as described by Nesheim and coworkers (3). Purified factor V is supplied in 50% glycerol (vol/vol), and should be stored at -20°C. Purity is determined by SDS-PAGE analysis and activity is measured in a factor V clotting assay. 

Properties of Factor V

*determined for bovine factor V
**determined for human factor V
***based upon the calculated molecular weight of human factor V

PURCHASING AND PRODUCT INFORMATION

References 
1. Mann, K.G., et al., Ann. Rev. Biochem., 57, 915 (1988). 
2. Katzmann, J.A., et al., Proc. Natl. Acad. Sci. USA, 78, 162 (1981). 
3. Nesheim, M.E., et al., J. Biol. Chem., 254, 508 (1979). 
4. Tracy, P.B., et al., Blood, 60, 59 (1982). 
5. Nesheim, M.E., et al., Methods Enzymol., 80, 249 (1981). 
6. Jenny, R.J., et al., Proc. Natl. Acad. Sci. USA, 84, 4846 (1987).